Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if the study drug entecavir will
prevent the recurrence of hepatitis B virus (HBV) in participants who receive an orthotopic
liver transplant (OLT) due to HBV infection.